Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The immune escape in melanoma: role of the impaired dendritic cell function.
Tucci M, Stucci S, Passarelli A, Giudice G, Dammacco F, Silvestris F. Tucci M, et al. Among authors: passarelli a. Expert Rev Clin Immunol. 2014 Oct;10(10):1395-404. doi: 10.1586/1744666X.2014.955851. Epub 2014 Sep 2. Expert Rev Clin Immunol. 2014. PMID: 25225774 Review.
Thymus-independent T-cell differentiation in vitro.
Sanchez M, Alfani E, Visconti G, Passarelli AM, Migliaccio AR, Migliaccio G. Sanchez M, et al. Among authors: passarelli am. Br J Haematol. 1998 Dec;103(4):1198-205. doi: 10.1046/j.1365-2141.1998.01155.x. Br J Haematol. 1998. PMID: 9886342 Free article.
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients.
D'Arena G, Simeon V, Laurenti L, Cimminiello M, Innocenti I, Gilio M, Padula A, Vigliotti ML, De Lorenzo S, Loseto G, Passarelli A, Di Minno MND, Tucci M, De Feo V, D'Auria F, Silvestris F, Di Minno G, Musto P. D'Arena G, et al. Among authors: passarelli a. Leuk Lymphoma. 2017 Nov;58(11):2633-2641. doi: 10.1080/10428194.2017.1306648. Epub 2017 Apr 3. Leuk Lymphoma. 2017. PMID: 28367662
Oligometastatic prostate cancer treatment.
Rossetti S, Di Napoli M, Pisano C, C Cecere S, Tambaro R, Ventriglia J, Passarelli A, Iovane G, Feroce F, Lastoria S, Di Gennaro F, Muto P, Borzillo V, Di Franco R, Perdonà S, Quarto G, Pignata S. Rossetti S, et al. Among authors: passarelli a. Future Oncol. 2021 Oct;17(29):3893-3899. doi: 10.2217/fon-2021-0126. Epub 2021 Jul 23. Future Oncol. 2021. PMID: 34296622
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group.
Bartoletti M, Bergamini A, Giannone G, Nero C, Musacchio L, Farolfi A, Passarelli A, Kuhn E, Castaldo D, Lombardo V, Di Palma T, Lorusso D, Puglisi F, De Giorgi U, Valabrega G, Schettino C, Scambia G, Capoluongo E, Pignata S. Bartoletti M, et al. Among authors: passarelli a. Int J Gynecol Cancer. 2022 Mar 21:ijgc-2022-003425. doi: 10.1136/ijgc-2022-003425. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35314461 No abstract available.
113 results